AstraZeneca responds to the Netherlands and Ireland's suspension of the use of its vaccine
The Netherlands and Ireland suspended the use of the "AstraZeneca" vaccine temporarily after reports of blood clots after vaccination with the vaccine in Norway, at a time when the company confirmed that it had conducted a review of those who received its Corona virus vaccine and resulted in no evidence of an increased risk of blood clots.
The Dutch decision came after an Irish person suspended the vaccine, as Dr Ronan Glen, deputy chief medical officer in Ireland, said that the recommendation was made after the Norwegian Medicines Agency reported four cases of blood clots among adults after they received the AstraZeneca vaccine.
He added that although there is no conclusive link between the vaccine and infection, Irish health officials have recommended that the vaccine be suspended as a precaution.
"A careful review of all potential safety data for more than 17 million people who got vaccinated from Covid-19 with the AstraZeneca vaccine in the European Union and Britain has not shown evidence of an increased risk of pulmonary embolism, deep vein thrombosis or platelet count in any specific age group or A certain gender or any specific country
The authorities in Denmark, Norway and Iceland suspended the use of the vaccine for problems related to clotting, while Austria stopped the use of a batch of doses of AstraZeneca last week pending an investigation of the death caused by blood clotting disorders.
For its part, the UK Drug Regulatory Authority confirmed that "reports of blood clots are not greater than the number that would have been recorded naturally among the vaccinated population, and that" the available evidence does not confirm that the vaccine is the cause. "
She stated that individuals still needed to get vaccinated when asked to do so.
The European Medicines Agency said that there is no evidence that these cases are related to the vaccine, an opinion the World Health Organization also went to on Friday.
The company said it and European health authorities had conducted additional tests without showing cause for concern.
She added that there are also no confirmed problems with the quality of any batches of her coronavirus vaccine used across Europe and the world.
The health authorities in the European Union and many countries have approved the use of the AstraZeneca vaccine, which was developed by the company in cooperation with the University of Oxford, but US regulatory agencies have not yet approved it.
Follow our latest local and sports news, and the latest political and economic developments via Google news